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Depressive and anxiety disorders are the most common psychiatric
condition encountered in primary healthcare, and are the leading
neuropsychiatric causes of the global burden of disease.1,2 Despite
strong evidence on the efficacy of specific treatments for
depressive and anxiety disorders, notably antidepressant
medication and brief structured psychological treatments,3 up to
90% of primary care attendees with these common mental
disorders in low- and middle-income countries do not receive
these.4 One major barrier to improving access to evidence-based
treatments for common mental disorders is the lack of trained
personnel in primary care to provide psychological treatments
and case management, which are essential to facilitate recovery
from these disorders.
The aim of the trial was to test the effectiveness of a lay health
counsellor led collaborative stepped-care intervention for
common mental disorders (the MANAS intervention) in
individuals attending public and private primary healthcare
facilities in Goa, India. The stepped-care model has been shown
to be associated with consistently superior outcomes compared
with usual care, although almost all trials are from high-income
countries5 with the exception of one trial from Chile,6 and all
focused only on depression. The MANAS trial sought to examine
how to extend the reach of proven depression treatments to
resource-poor primary care settings in two key ways: first, the
intervention was designed for delivery by lay health workers;
and second, it was designed to be appropriate for the full range
of common anxiety and depressive disorders seen in primary care.
Earlier, we published the findings of the impact of the
intervention on primary mental health outcomes (recovery from
ICD-10 common mental disorders7) at the primary end-point of
6 months.8 Those analyses found that there was a modest benefit
on these outcomes (risk ratio RR= 1.22, 95% CI 1.00–1.47), but
also that the benefits were only evident in patients attending pub-
lic facilities (RR= 1.55, 95% CI 1.02–2.35); no impact was found
in people attending private facilities (RR= 0.95, 95% CI 0.74–
1.22). This paper extends those findings and describes the impact
of the intervention at three time points over the 12 months
following trial enrolment on a wider range of outcomes, including
mental health, suicidal behaviour and disability. The trial has been
registered with clinicaltrials.gov (NCT00446407).
Method
Setting
The trial was conducted in Goa, a state in West India, by a
consortium of organisations led by Sangath, in collaboration with
the Government of Goa’s Directorate of Health Services, the
Voluntary Health Association of Goa, private general practitioners
and the London School of Hygiene & Tropical Medicine.
Hypothesis
A collaborative stepped-care intervention led by lay health
counsellors will reduce the prevalence of common mental disorders
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Background
Depressive and anxiety disorders (common mental disorders)
are the most common psychiatric condition encountered in
primary healthcare.
Aims
To test the effectiveness of an intervention led by lay health
counsellors in primary care settings (the MANAS intervention)
to improve the outcomes of people with common mental
disorders.
Method
Twenty-four primary care facilities (12 public, 12 private) in
Goa (India) were randomised to provide either collaborative
stepped care or enhanced usual care to adults who
screened positive for common mental disorders. Participants
were assessed at 2, 6 and 12 months for presence of ICD-10
common mental disorders, the severity of symptoms of
depression and anxiety, suicidal behaviour and disability
levels. All analyses were intention to treat and carried out
separately for private and public facilities and adjusted for
the design. The trial has been registered with
clinicaltrials.gov (NCT00446407).
Results
A total of 2796 participants were recruited. In public facilities,
the intervention was consistently associated with strong
beneficial effects over the 12 months on all outcomes. There
was a 30% decrease in the prevalence of common mental
disorders among those with baseline ICD-10 diagnoses (risk
ratio (RR) = 0.70, 95% CI 0.53–0.92); and a similar effect
among the subgroup of participants with depression
(RR= 0.76, 95% CI 0.59–0.98). Suicide attempts/plans showed
a 36% reduction over 12 months (RR= 0.64, 95% CI 0.42–0.98)
among baseline ICD-10 cases. Strong effects were observed
on days out of work and psychological morbidity, and
modest effects on overall disability. In contrast, there was
little evidence of impact of the intervention on any outcome
among participants attending private facilities.
Conclusions
Trained lay counsellors working within a collaborative-care
model can reduce prevalence of common mental disorders,
suicidal behaviour, psychological morbidity and disability days
among those attending public primary care facilities.
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in individuals over a 12-month period. Secondary hypotheses
tested the effect of the intervention on reduction of symptom
severity, suicidal behaviour and disability levels.
Design
A stratified cluster randomised design with health facility as the
unit of randomisation. The trial was conducted in two consecutive
phases from April 2007 to September 2009. Phase 1 involved 12
public facilities, whereas Phase 2 was conducted in 12 private
facilities.
Selection of facilities and randomisation
In Phase 1, the sampling frame included all public primary
healthcare facilities with the space for lay health counsellors and
that were not involved in preliminary phases related to inter-
vention development.9,10 In Phase 2, we invited the participation
of private general practitioners (GPs) through letters to over 400
registered practitioners; however, as the response rate was poor
the research team then visited a subsample of practitioners who
had not responded. Through this process, 22 eligible facilities were
identified of which 12 were randomly selected for inclusion in the
trial. Details of the process of identification and stratification of
facilities are described elsewhere.8 Facilities were randomly
allocated within each stratum to either the intervention or control
arm using a 1:1 allocation ratio by the trial statistician (H.W.)
using the website www. randomization.com.
Participants
All primary care patients aged over 17 years were screened with
the 12-item General Health Questionnaire (GHQ-12)11 using a
cut-off score of 5/6 to identify ‘screen-positive’ individuals based
on psychometric properties evaluated in these settings.10 Eligibil-
ity criteria for participation in the trial were: screening positive for
common mental disorders; being resident in Goa for the subse-
quent 12 months; speaking Konkani, Marathi, Hindi or English;
not requiring urgent medical attention; and not having difficulty
with hearing, speaking or cognition that makes interviewing
difficult. If the individual gave written or verbal consent, a
structured clinical diagnostic interview (the Revised Clinical
Interview Schedule or CIS-R)12 (see below) was administered to
provide a baseline assessment of severity and ICD-10 diagnostic
categorisation.7 Based on these assessments, trial participants were
categorised into four a priori groups for analyses: all participants
(screen-positive group); the subgroup of those who screened
positive who had ICD-10 diagnoses of common mental disorders
(ICD-10 diagnosis group); the subgroup of those with ICD-10
common mental disorder diagnoses with the specific diagnosis
of depression (depression subgroup); and the subgroup of those
who screened positive who did not meet ICD-10 criteria for
common mental disorders13 (subthreshold subgroup).
Sample size
Sample size estimates have been described in detail previously.13
Briefly, we assumed: a coefficient of variation of 0.2; prevalence
of ICD-10 common mental disorders of 66% among participants
who screened positive; follow-up of 75% at 6 months. The
resulting sample of 100 participants who screened positive in 24
clusters provides over 90% power to detect a difference in recovery
rates of 70% in the collaborative stepped-care arm v. 50% in the
enhanced usual care control arm, estimates based on earlier
efficacy trials in Goa14 and Chile.15 The observed value of kappa
was 0.08 (equivalent to an intraclass correlation coefficient of
0.03) indicating relatively little between-cluster variability within
the strata.8
Interventions
All interventions were implemented at the individual level within
clusters.
The collaborative stepped-care intervention
The intervention was developed following a systematic process
that has been described previously.9 In brief, the intervention is
based on a stepped-care approach that emphasises that relatively
simple interventions such as psychoeducation are provided to all
patients, more resource-intensive interventions are reserved for
individuals who are severely ill or not responding to the simpler
interventions. The collaborative approach involves three key team
members: the lay health counsellor, the primary care physician
and a visiting psychiatrist (clinical specialist). The lay health
counsellors had non-healthcare backgrounds and underwent a
structured 2-month training course.16 Each facility team was
supported by a psychiatrist who visited about once a month and
was also available for consultation on the phone. Each lay health
counsellor acted as a case manager for participants who screened
positive for common mental disorders and took overall
responsibility for delivering all non-drug treatments, in
collaboration with the primary care physician and the visiting
psychiatrist, with the ultimate goal of a planned discharge upon
recovery. Individuals could be discharged either in a planned
manner (for example, recovered) or unplanned (for example,
did not return despite adherence interventions).
There were four components to the intervention. First, all
patients were offered psychoeducation, which involved
explanation about the nature of the symptoms; the association
of common mental disorders with interpersonal difficulties; the
need to share emotional symptoms with the doctor and to share
personal difficulties with caring family members or other key
persons in their social network; strategies for symptom alleviation,
for example breathing exercises for anxiety symptoms; the need
for adherence to other treatments; and providing information
about social/welfare agencies when required. Antidepressants were
recommended for moderate or severe common mental disorders
and for individuals who did not respond to psychoeducation
alone on the basis of routine clinical assessments by the lay health
counsellor. In the public facilities, the antidepressant of choice,
fluoxetine, was provided free. In the private facilities, doctors
could prescribe antidepressants of their choice, which were
purchased by patients as usual. Once initiated, antidepressants
were recommended for a minimum of 90 days at an adequate dose
(for example, at least 20mg per day of fluoxetine). Physicians were
given training over half a day and a manual. Physicians were asked
to encourage participants to meet the lay health counsellor, to avoid
the use of unnecessary medications and to provide usual care for any
coexisting physical health problems. Interpersonal psychotherapy
delivered by the lay health counsellor was offered to participants
who had moderate or severe common mental disorders, either in
addition to antidepressants or as an alternative to antidepressants
for those who did not respond to them. Interpersonal
psychotherapy was chosen because of it demonstrated effectiveness
in another low-income country,17 and for its focus on interpersonal
problems such as grief, disputes and role transitions, which were
common themes in the adverse life experiences among individuals
with common mental disorders in Goa.18 A minimum of six
sessions were offered. Referral to a visiting psychiatrist was reserved
for individuals who were unresponsive to the earlier treatments;
were assessed to be at high suicide risk at any stage; had significant
comorbidity with alcohol dependence; had associated significant
other medical problems; posed diagnostic dilemmas; or for whom
the primary care physician requested a consultation.
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Control intervention – enhanced usual care
Physicians in usual care practices received screening results and
were given a treatment manual prepared for primary care physicians.
They were allowed to initiate treatments of their choice.
Measurement and outcomes
The mental health outcomes were assessed using the CIS-R, a
structured interview for use by trained lay interviewers.12 The
CIS-R is one of the most widely used measures of common
mental disorders globally with extensive prior use in the study
setting.14,19,20 The disability outcomes were assessed using the
12-item WHO Disability Assessment Schedule (WHODAS II),21
a brief questionnaire that has been used in Goa22,23 previously
and has been used in the World Health Surveys. Both measures
were used at each follow-up time point. Based on the trial
protocol (http://clinicaltrials.gov/ct2/show/NCT00446407?term=
MANAS&rank=1), the following outcomes are reported in this
paper.
(a) Prevalence of common mental disorders, computed from an
algorithm that generates ICD-10 diagnoses from CIS-R
responses.
(b) Mean CIS-R score, computed from the total of the CIS-R items.
(c) Days of no work or reduced work in previous month,
computed from two WHODAS items that ask about each of
these two experiences.
(d) Any reported suicide plans or attempt, computed from two
items that ask about these in the CIS-R.
(e) WHODAS scores, computed from the total score of the 12
WHODAS scoring items.
Research assessors underwent 2 weeks’ training in the use of
the interview and quality assurance, including using hand-held
electronic personal digital assistants to collect data.
Masking
Masking of the research assessor was maximised by: carrying out
evaluations at home and by an independent research institution
not associated with the intervention; randomly allocating unique
participant IDs; and carrying out the primary outcome assessment
prior to all other assessments.
Analyses
The primary analyses showed consistent effect modification
between public and private facilities, for all outcomes.7 Therefore
in this paper, we have stratified all analyses by facility type.
Furthermore, analyses testing for effect modification by type of
facility over the 12-month period showed consistent evidence of
effect modification for all outcomes except suicide (online Tables
DS1 and DS2), confirming our decision to present stratified
results in the paper. Intention-to-treat analyses were based on
cluster-level summary values for each of the outcomes, the
recommended approach for cluster randomised trials with fewer
than 15 clusters per arm.24 The overall common mental disorders
prevalence was estimated as the geometric mean of the cluster
(facility) prevalences (summing across the three visits) within each
arm. For suicide plans/attempts, one cluster had zero outcomes,
and so the arithmetic mean of cluster suicide prevalences was
estimated. For continuous outcomes, the overall means were
estimated as the arithmetic mean of the cluster-level mean scores
within each arm. For CIS-R scores, results are presented as the
mean score and the mean percentage change in score from baseline.
Risk ratios were estimated using data from all follow-up time
points (maximum of three) for which there were data. Although
missing data at baseline was associated with age and gender, there
was no evidence that this was associated with outcomes measured
at follow-up, suggesting that the data were missing at random
after conditioning on age and gender. Thus, data were not
imputed, and analyses excluding missing data but adjusted for
age and gender should be unbiased. Risk ratio estimation also
assumed a constant effect during follow-up. To test this
assumption, we used an extension of the method of Cheung et
al25 to test evidence for a linear trend in intervention effect over
time, and also tested for effect modification between the effect
at 2 and 12 months respectively to assess whether the effect waned
over time.
All intervention–control comparisons were adjusted for: the
imbalance between arms of case type at baseline (depression,
anxiety, subthreshold symptoms); age and gender, since the
probability of missing data was associated with these at baseline;
and within-individual correlation between visits. For binary
outcomes, adjustment was done by calculating the expected
number of cases at each time point in each cluster using
generalised estimating equation logistic regression, adjusting for
strata, case type, age and gender and within-individual correlation
between visits. The total expected number of cases over the three
visits in each cluster was then compared with the total observed
number, and expressed as a ratio of total observed/total expected.
The adjusted risk ratio (RR) was obtained as the ratio of the
geometric mean of the cluster total observed/total expected ratios
in the intervention arm compared with the geometric mean of the
cluster ratios in the control arm. An approximate variance for the
log risk ratio in each arm was obtained from the residual mean
square from a two-way analysis of variance of cluster log (total
observed/total expected) on stratum and study arm. A 95%
confidence interval for the risk ratio was calculated from this
variance using a stratified t-statistic.24 For the continuous
outcomes, the analogous analysis was carried out using linear
regression. Details of trial protocol approval and consent have
been published previously.13
Results
The trial flow chart is shown in Fig. 1. The trial population was
predominantly female (82%), with a mean age of 46.3 years
(s.d. = 13.3). Of the 2242 (81%) with an ICD-10 diagnosis at
baseline (ICD-10 diagnosis group), 774 (35%) had depression,
including comorbid anxiety disorders (depression subgroup).
The most common diagnosis was mixed anxiety–depressive
disorder (n=1032; 46% of all those with common mental
disorders); the remaining 436 (19%) had a ‘pure’ anxiety disorder.
In general, there was good balance between arms; although
participants in the enhanced usual care arm were more likely to
have depression, the proportion of those with ICD-10 diagnosis
and mean CIS-R scores were similar. The proportions completing
the outcome assessment were were 89% at month 2, 87% at
month 6 and 85% at month 12. Overall, 2181 (78%) of all
screen-positive participants were seen at all three follow-up visits.
Among the primary analysis group of those with an ICD-10
diagnosis, the overall proportion with complete follow-up
data was 79%. The proportion of participants with complete
follow-up data was higher in the enhanced usual care arm than
the collaborative stepped-care arm (80.9% v. 76.5%, P= 0.01).
Impact on mental health outcomes
In participants attending the public facilities, there was a strong
impact of the intervention on reduced prevalence of common
mental disorders in all analysis groups at all three time points
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(Fig. 2). The overall effect was a 30% reduction in prevalence in the
ICD-10 diagnosis group between arms (P=0.02); 24% reduction
in the depression subgroup (P=0.04); 34% reduction in the
screen-positive group (P= 0.03); and 57% reduction in the sub-
threshold subgroup (P=0.11) (Table 1). There was no evidence
that the size of the effect differed over time on a relative scale
(P40.20 in each diagnostic group). The absolute difference in risk
did appear to decrease from about 20% at 2 months to 12% at 12
months for all except those in the subthreshold subgroup, where it
was 18% at each time point. However, this difference was not sta-
tistically significant (P40.1 in each diagnostic group). Among all
those who screened positive, treatment of five individuals will
avert an average of one common mental disorder case at 2
months, and treatment of seven people will avert one case at 12
months. In contrast, no impact was observed in any analysis group
among participants attending private facilities.
A similar picture emerged on analyses of the impact of the
intervention on severity of symptoms. In public facility participants,
the CIS-R scores in the intervention arm decreased by about 50%
in all but the subthreshold subgroup by 2 months, compared with
a decrease of about 30% in the controls. The difference persisted
to 12 months (Fig. 3, Table 2) with no significant trend in effect
over time. Again, no effect was observed in any analysis group
among participants attending private facilities.
There was a generally high prevalence (14.0%) of reported
suicide plans or attempts over the 12 months of follow-up, but
evidence of a beneficial effect in the public facilities: 36%
reduction in the ICD-10 group between arms (P=0.04) and
45% reduction in the depression group (P= 0.06). Similar
reductions were seen in the private facilities, but these were not
significant, partly because of the smaller sample size and slightly
greater variability in prevalence between clinics.
Impact on disability
In the public facilities, there was evidence of an intervention effect
on disability days (no work or reduced work) reported in the
previous month in all diagnostic groups (Table 3; Fig. 5), with
participants in the intervention arm reporting 4–5 fewer days of
disability in the previous month than those in the control arm.
As with all other outcomes, there was no impact observed in
private facility participants.
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Allocated to intervention (CSC):
6 clusters (n = 823)
Mean per cluster 136,
range 114–150
Received allocated intervention:
6 clusters (n = 818)
Did not receive allocated
Intervention: 0 clusters (n = 5)
Analysed for 2-month outcomes:
6 clusters (n = 704; 86%)
Mean per cluster 116,
range 104–130
Analysed for 6-month outcomes:
6 clusters (n = 684, 83%)
Mean per cluster 112,
range 90–131
Analysed for 12-month outcomes:
6 clusters (n = 685, 83%)
Mean per cluster 112,
range 90–132
6
6
6
6
Public facilities assessed for eligibility: 49 clusters
Excluded: 32 clusters
Did not meet inclusion criteria: 32 clusters
Randomised: 12 clusters (n = 1648)
Back-up public
facilities: 5
6
6
7
Allocated to control (EUC):
6 clusters (n = 825)
Mean per cluster 131,
range 84–150
Received allocated intervention:
6 clusters (n = 825)
Did not receive allocated
intervention:
0 clusters (n = 0)
Analysed for 2-month outcomes:
6 clusters (n = 733, 89%)
Mean per cluster 116,
range 74–145
Analysed for 6-month outcomes:
6 clusters (n = 732, 89%)
Mean per cluster 114,
range 68–145
Analysed for 12-month outcomes:
6 clusters (n = 701, 85%)
Mean per cluster 108,
range 61–144
6
6
6
6
Private facilities assessed for eligibility: 68 clusters
Excluded: 46 clusters
Did not meet inclusion criteria: 25 clusters
Refused to participate: 21 clusters
Randomised: 12 clusters (n = 1148)
Allocated to intervention (CSC):
6 clusters (n = 537)
Mean per cluster 87,
range 64–109
Received allocated intervention:
6 clusters (n = 537)
Did not receive allocated
Intervention: 0 clusters (n = 0)
Analysed for 2-month outcomes:
6 clusters (n = 482; 90%)
Mean per cluster 77,
range 55–101
Analysed for 6-month outcomes:
6 clusters (n = 476, 89%)
Mean per cluster 75,
range 52–98
Analysed for 12-month outcomes:
6 clusters (n = 460, 86%)
Mean per cluster 74,
range 52–90
Allocated to control (EUC):
6 clusters (n = 611)
Mean per cluster 102,
range 99–112
Received allocated intervention:
6 clusters (n = 611)
Did not receive allocated
intervention:
0 clusters (n = 0)
Analysed for 2-month outcomes:
6 clusters (n = 572, 94%)
Mean per cluster 95,
range 86–110
Analysed for 6-month outcomes:
6 clusters (n = 537, 88%)
Mean per cluster 89,
range 77–103
Analysed for 12-month outcomes:
6 clusters (n = 521, 85%)
Mean per cluster 86,
range 73–199
Back-up GP
facilities: 10 clusters
Drop-out
GP facility:
1 cluster replaced
by back-up facility
6
6
6
6
6
6
6
6
6
6
7
7
Fig. 1 Trial flow chart.
PHC, Public health centre; GP, general practitioner, CSC, collaborative stepped care; EUC, enhanced usual care.
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There were trends towards reductions in WHODAS total
disability scores observed in public facility participants, but these
did not reach statistical significance (online Figs DS1 and DS2,
Table DS3).
Discussion
Main findings
The MANAS collaborative stepped-care intervention led by lay
health counsellors reduced the prevalence of ICD-10 common
mental disorders and the severity of symptoms of depression
and anxiety in individuals attending public primary healthcare
facilities with a common mental disorder (defined either on the
basis of a formal diagnostic interview or a screening question-
naire) and in the subgroup of individuals with depression, over
a 12-month period following enrolment in the trial. The
intervention also showed benefits in reduction in the risk of
suicidal behaviours (plans or attempts) and disability days (days
of no work or reduced work) and weaker effects on overall
disability scores in these participants. Although some benefit
was noted in reduction in the prevalence of ICD-10 common
mental disorders, psychological morbidity scores and disability
days in those in the subthreshold subgroup, in general these
were of a smaller magnitude and weaker statistical significance.
Moreover, no impact was observed on any outcome, apart from
a non- significant reduction in the risk of suicidal behaviours,
for any diagnostic group in participants attending private primary
healthcare facilities.
The findings in this paper extend in three important ways the
findings of the 6-month primary end-point analyses8 that the
intervention improved the mental health outcomes of people with
common mental disorders, and that these benefits are only evident
in public primary care attendees. First, they show substantial
benefits sustained across the 12-month follow-up period on both
clinical outcomes in individuals attending public healthcare
facilities. Second, they demonstrate an overall benefit for the
diagnostic subgroup of individuals with depression in these
longitudinal analyses. Third, they demonstrate the impact of the
intervention on suicidal behaviour and disability outcomes, both
of which are important health outcomes in their own right. To
the best of our knowledge, this is the first trial from a low- and
middle-income country demonstrating the impact of inter-
ventions for a mental disorder on suicidal behaviours, a major
public health priority in these countries.26 The apparently larger
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Fig. 2 Impact of the intervention on prevalence of ICD-10 common mental disorders (CMD) at 2, 6 and 12 months (m). (a) Public facilities,
(b) private facilities.
Table 1 Impact of intervention on prevalence of ICD-10 common mental disorders over 12 months
Public facilities Private facilities
Diagnostic group at baseline n (%) RR (95% CI)a P n (%) RR (95% CI)a P
ICD-10 diagnosis group N=3382 0.70 (0.53– 0.92) 0.02 N=2487 1.18 (0.81–1.72) 0.34
Collaborative stepped care 574 (34.9) 437 (33.5)
Enhanced usual care 941 (53.2) 411 (30.9)
ICD-10 depression subgroup N=1219 0.76 (0.59–0.98) 0.04 N=802 1.20 (0.82–1.76) 0.31
Collaborative stepped care 180 (42.2) 153 (42.0)
Enhanced usual care 450 (58.1) 160 (36.1)
Screen-positive group N=4239 0.66 (0.45–0.95) 0.03 N=3048 1.13 (0.76–1.67) 0.50
Collaborative stepped care 647 (30.6) 470 (30.4)
Enhanced usual care 1087 (49.8) 482 (28.6)
Subthreshold subgroup N=857 0.43 (0.14–1.36) 0.11 N=561 0.63 (0.29–1.40) 0.22
Collaborative stepped care 73 (14.7) 33 (11.0)
Enhanced usual care 146 (32.6) 71 (16.6)
a. The risk ratio (RR) is adjusted for ‘case type’ at baseline, age at baseline, gender and repeated observations per individual.
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Table 2 Impact of intervention on psychological morbidity scores over 12 months
Public facilities Private facilities
Diagnostic group at baseline
Baseline
CIS-R score
Mean score (% change
over 12 months)
Mean differencea
(95% CI) P
Baseline
CIS-R score
Mean score (% change
over 12 months)
Mean differencea
(95% CI) P
ICD-10 diagnosis group 73.90 (77.61 to 70.19) 0.04 0.48 (72.10 to 3.06) 0.68
Collaborative stepped care 22.20 9.67 (757) 23.73 9.12 (762)
Enhanced usual care 22.69 13.85 (739) 21.93 8.74 (760)
ICD-10 depression subgroup 74.45 (79.14 to 0.19) 0.06 70.21 (73.13 to 2.71) 0.87
Collaborative stepped care 26.97 11.15 (758) 30.03 10.69 (764)
Enhanced usual care 26.41 15.43 (741) 26.83 10.14 (763)
Screen-positive group 73.89 (77.80 to 0.03) 0.05 0.33 (72.19 to 2.85) 0.77
Collaborative stepped care 19.02 8.77 (754) 21.25 8.57 (760)
Enhanced usual care 19.67 12.95 (734) 19.03 8.21 (757)
Subthreshold symptoms subgroup 73.22 (77.61 to 1.18) 0.11 70.70 (73.02 to 1.62) 0.51
Collaborative stepped care 7.41 5.81 (721) 8.00 5.29 (734)
Enhanced usual care 6.98 8.87 (27) 7.57 5.90 (722)
a. Adjusted for difference in baseline Revised Clinical Interview Schedule (CIS-R) score, age at baseline, gender and repeated observations by individuals.
Table 3 Impact of intervention on total disability days in past 30 days (no work or reduced work) over 12 months
Public facilities Private facilities
Diagnostic group at baseline Mean Mean differencea (95% CI) P Mean Mean differencea (95% CI) P
ICD-10 diagnosis group 74.43 (78.37 to 70.48) 0.04 0.78 (72.25 to 3.82) 0.57
Collaborative stepped care 6.65 9.68
Enhanced usual care 11.56 8.87
ICD-10 depression group 74.77 (79.87 to 0.34) 0.06 0.34 (72.89 to 3.57) 0.82
Collaborative stepped care 7.35 11.01
Enhanced usual care 12.64 9.77
Screen-positive group 74.57 (78.64 to 70.50) 0.04 0.64 (72.33 to 3.60) 0.63
Collaborative stepped care 6.16 9.14
Enhanced usual care 11.19 8.31
Subthreshold symptoms group 74.83 (79.50 to 70.16) 0.05 70.66 (74.55 to 3.23) 0.71
Collaborative stepped care 4.50 6.11
Enhanced usual care 9.22 6.15
a. Adjusted for difference in baseline Revised Clinical Interview Schedule (CIS-R) score, age at baseline, gender and repeated observations by individuals.
Lay health worker led intervention for depressive and anxiety disorders
absolute effects of the intervention in the short-term are in line
with other trials for the treatment of common mental disorders,
including those in this study setting,14,27 although the difference
in effect over time was not statistically significant in our study.
Process indicators for the intervention up to 6 months, which
marked the maximum intervention period, were published earlier;8
they showed excellent uptake of the low-intensity psychoeducation
component, moderate uptake of the antidepressant component
and low uptake of the more intensive interpersonal psychotherapy
component. It may be argued that more intensive and longer
treatments, such as aggressive pharmacotherapy and structured
psychological treatments, could further increase the size and
durability of the effect of the intervention.
The large difference in effect by facility type (public or private)
may be attributed to at least two key factors: first, that the great
difficulty we had in enroling GPs from private facilities meant that
those who did participate were a non-representative, highly
motivated group of practitioners committed to care for common
mental disorders. Second, it is possible that the ‘personalised
client-centred’ care that characterises such private practices28
cancelled out the added value of the lay health counsellor in the
intervention. Preliminary findings from in-depth interviews with
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the participating practitioners supports the latter possibility. It is
notable that our intervention was able to lead to outcomes in
public facility attendees that were at least as good as those
observed in private facility patients.
Implications
The MANAS trial is the largest such trial in psychiatry from a low-
and middle-income country. Apart from the limited coverage of
the high-intensity psychological treatment component of the
intervention, the trial was able to achieve all its a priori
recruitment, intervention and follow-up targets. Based on our
findings, we recommend the extension of the MANAS model to
public primary healthcare facilities in India. Future research
should focus on promoting the development and evaluation of
culturally appropriate, affordable and acceptable psychological
treatments, and more aggressive and longer-term management
in those individuals whose condition is refractory.
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Table DS1 Impact on common mental disorder prevalence and suicide attempts/plans over 12 months in private and public
facilities combined
Diagnostic group at baseline Common mental disorder prevalence Suicide attempts/plans
ICD-10 diagnosis group
Collaborative stepped care, n (%) 1011 (34.2) 83 (8.9)
Enhanced usual care, n (%) 1352 (40.6) 196 (18.6)
Risk ratio (95% CI)a 0.90 (0.72–1.13) 0.60 (0.26–1.37)
P for risk ratio = 1 0.34 0.20
P for effect modification by phase 0.01 0.82
ICD-10 depression subgroup
Collaborative stepped care, n (%) 333 (42.1) 28 (13.9)
Enhanced usual care, n (%) 610 (45.8) 106 (22.6)
Risk ratio (95% CI)a 0.95 (0.76–1.19) 0.59 (0.32–1.11)
P for risk ratio = 1 0.62 0.10
P for effect modification by phase 0.03 0.73
Screen-positive group
Collaborative stepped care, n (%) 1117 (30.5) 96 (8.5)
Enhanced usual care, n (%) 1569 (37.7) 225 (17.4)
Risk ratio (95% CI)a 0.85 (0.66–1.09) 0.60 (0.25–1.46)
P for risk ratio = 1 0.18 0.24
P for effect modification by phase 0.02 0.73
Subthreshold symptoms subgroup
Collaborative stepped care, n (%) 106 (12.7) 13 (5.1)
Enhanced usual care, n (%) 217 (23.5) 29 (12.5)
Risk ratio (95% CI)a 0.52 (0.29–0.92) 0.66 (0.34–1.29)
P for risk ratio = 1 0.03 0.20
P for effect modification by phase 0.55 0.53
a. The risk ratio is adjusted for ‘case type’ at baseline, age at baseline, gender and repeated observations per individual.
Table DS2 Impact on mean Revised Clinical Interview Schedule (CIS-R) score, total disability days, and World Health
Organization Disability Assessment Schedule II (WHODAS) scores over 12 months
Diagnostic group at baseline Mean CIS-R score
Total disability days
in past 30 days WHODAS disability scores
ICD-10 diagnosis group
Collaborative stepped care, n (%) 9.39 (759.1) 8.16 16.69
Enhanced usual care, n (%) 11.29 (749.4) 10.21 17.11
Mean difference (95% CI)a 71.81 (73.65 to 0.04) 71.92 (73.99 to 0.14) 70.27 (71.52 to 0.99)
P for risk ratio = 1 0.05 0.07 0.65
P for effect modification by phase 0.02 0.02 0.08
ICD-10 depression subgroup
Collaborative stepped care, n (%) 10.95 (761.6) 9.18 17.07
Enhanced usual care, n (%) 12.82 (751.9) 11.20 17.68
Mean difference (95% CI)a 72.15 (74.29 to 70.01) 72.34 (74.75 to 0.07) 70.56 (71.75 to 0.64)
P for risk ratio = 1 0.05 0.07 0.33
P for effect modification by phase 0.06 0.08 0.07
Screen-positive group
Collaborative stepped care, n (%) 8.66 (757.0) 7.66 16.44
Enhanced usual care, n (%) 10.58 (745.3) 9.75 16.84
Mean difference (95% CI)a 71.90 (73.79 to 70.01) 72.05 (74.11 to 0.02) 70.28 (71.52 to 0.95)
P for risk ratio = 1 0.05 0.05 0.63
P for effect modification by phase 0.03 0.02 0.08
Subthreshold symptoms subgroup
Collaborative stepped care, n (%) 5.55 (727.9) 5.31 15.50
Enhanced usual care, n (%) 7.39 (71.5) 7.69 15.66
Mean difference (95% CI)a 72.03 (74.04 to 70.01) 72.73 (75.30 to 70.15) 70.26 (71.39 to 0.88)
P for risk ratio = 1 0.05 0.04 0.63
P for effect modification by phase 0.20 0.10 0.06
a. The risk ratio is adjusted for ‘case type’ at baseline, age at baseline, gender and repeated observations per individual.
2Table DS3 Impact of intervention on World Health Organization Disability Assessment Schedule II scores over 12 months
Diagnostic group at baseline Public health centre facilities Private general practitioner facilities
ICD-10 diagnosis group
Collaborative stepped care, n (%) 16.69 16.70
Enhanced usual care, n (%) 18.16 16.07
Mean difference (95% CI)a 71.30 (73.33 to 0.73) 0.79 (71.16 to 2.73)
P 0.15 0.38
ICD-10 depression subgroup
Collaborative stepped care, n (%) 16.90 17.23
Enhanced usual care, n (%) 18.69 16.67
Mean difference (95% CI)a 71.84 (74.33 to 0.65) 0.39 (71.99 to 2.76)
P 0.11 0.72
Screen-positive group
Collaborative stepped care, n (%) 16.34 16.54
Enhanced usual care, n (%) 17.80 15.85
Mean difference (95% CI)a 71.28 (73.24 to 0.68) 0.77 (71.13 to 2.68)
P 0.14 0.37
Subthreshold symptoms subgroup
Collaborative stepped care, n (%) 15.21 15.79
Enhanced usual care, n (%) 16.43 14.89
Mean difference (95% CI)a 71.22 (72.89 to 0.46) 0.74 (71.05 to 2.53)
P 0.11 0.37
a. Adjusted for difference in baseline Revised Clinical Interview Schedule (CIS-R) score, age at baseline, gender and repeated observations by individuals.
3Fig. DS1 Impact of intervention on disability days (days out of or of reduced work in previous 30 days) at 2, 6 and 12 months. (a) Public
facilities, (b) private facilities.
Fig. DS2 Impact of the intervention on total disability scores (World Health Organization Disability Assessment Schedule II (WHODAS))
at 2, 6 and 12 months. (a) Public facilities, (b) private facilities.
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Table DS1 Impact on common mental disorder prevalence and suicide attempts/plans over 12 months in private and public
facilities combined
Diagnostic group at baseline Common mental disorder prevalence Suicide attempts/plans
ICD-10 diagnosis group
Collaborative stepped care, n (%) 1011 (34.2) 83 (8.9)
Enhanced usual care, n (%) 1352 (40.6) 196 (18.6)
Risk ratio (95% CI)a 0.90 (0.72–1.13) 0.60 (0.26–1.37)
P for risk ratio = 1 0.34 0.20
P for effect modification by phase 0.01 0.82
ICD-10 depression subgroup
Collaborative stepped care, n (%) 333 (42.1) 28 (13.9)
Enhanced usual care, n (%) 610 (45.8) 106 (22.6)
Risk ratio (95% CI)a 0.95 (0.76–1.19) 0.59 (0.32–1.11)
P for risk ratio = 1 0.62 0.10
P for effect modification by phase 0.03 0.73
Screen-positive group
Collaborative stepped care, n (%) 1117 (30.5) 96 (8.5)
Enhanced usual care, n (%) 1569 (37.7) 225 (17.4)
Risk ratio (95% CI)a 0.85 (0.66–1.09) 0.60 (0.25–1.46)
P for risk ratio = 1 0.18 0.24
P for effect modification by phase 0.02 0.73
Subthreshold symptoms subgroup
Collaborative stepped care, n (%) 106 (12.7) 13 (5.1)
Enhanced usual care, n (%) 217 (23.5) 29 (12.5)
Risk ratio (95% CI)a 0.52 (0.29–0.92) 0.66 (0.34–1.29)
P for risk ratio = 1 0.03 0.20
P for effect modification by phase 0.55 0.53
a. The risk ratio is adjusted for ‘case type’ at baseline, age at baseline, gender and repeated observations per individual.
Table DS2 Impact on mean Revised Clinical Interview Schedule (CIS-R) score, total disability days, and World Health
Organization Disability Assessment Schedule II (WHODAS) scores over 12 months
Diagnostic group at baseline Mean CIS-R score
Total disability days
in past 30 days WHODAS disability scores
ICD-10 diagnosis group
Collaborative stepped care, n (%) 9.39 (759.1) 8.16 16.69
Enhanced usual care, n (%) 11.29 (749.4) 10.21 17.11
Mean difference (95% CI)a 71.81 (73.65 to 0.04) 71.92 (73.99 to 0.14) 70.27 (71.52 to 0.99)
P for risk ratio = 1 0.05 0.07 0.65
P for effect modification by phase 0.02 0.02 0.08
ICD-10 depression subgroup
Collaborative stepped care, n (%) 10.95 (761.6) 9.18 17.07
Enhanced usual care, n (%) 12.82 (751.9) 11.20 17.68
Mean difference (95% CI)a 72.15 (74.29 to 70.01) 72.34 (74.75 to 0.07) 70.56 (71.75 to 0.64)
P for risk ratio = 1 0.05 0.07 0.33
P for effect modification by phase 0.06 0.08 0.07
Screen-positive group
Collaborative stepped care, n (%) 8.66 (757.0) 7.66 16.44
Enhanced usual care, n (%) 10.58 (745.3) 9.75 16.84
Mean difference (95% CI)a 71.90 (73.79 to 70.01) 72.05 (74.11 to 0.02) 70.28 (71.52 to 0.95)
P for risk ratio = 1 0.05 0.05 0.63
P for effect modification by phase 0.03 0.02 0.08
Subthreshold symptoms subgroup
Collaborative stepped care, n (%) 5.55 (727.9) 5.31 15.50
Enhanced usual care, n (%) 7.39 (71.5) 7.69 15.66
Mean difference (95% CI)a 72.03 (74.04 to 70.01) 72.73 (75.30 to 70.15) 70.26 (71.39 to 0.88)
P for risk ratio = 1 0.05 0.04 0.63
P for effect modification by phase 0.20 0.10 0.06
a. The risk ratio is adjusted for ‘case type’ at baseline, age at baseline, gender and repeated observations per individual.
2Table DS3 Impact of intervention on World Health Organization Disability Assessment Schedule II scores over 12 months
Diagnostic group at baseline Public health centre facilities Private general practitioner facilities
ICD-10 diagnosis group
Collaborative stepped care, n (%) 16.69 16.70
Enhanced usual care, n (%) 18.16 16.07
Mean difference (95% CI)a 71.30 (73.33 to 0.73) 0.79 (71.16 to 2.73)
P 0.15 0.38
ICD-10 depression subgroup
Collaborative stepped care, n (%) 16.90 17.23
Enhanced usual care, n (%) 18.69 16.67
Mean difference (95% CI)a 71.84 (74.33 to 0.65) 0.39 (71.99 to 2.76)
P 0.11 0.72
Screen-positive group
Collaborative stepped care, n (%) 16.34 16.54
Enhanced usual care, n (%) 17.80 15.85
Mean difference (95% CI)a 71.28 (73.24 to 0.68) 0.77 (71.13 to 2.68)
P 0.14 0.37
Subthreshold symptoms subgroup
Collaborative stepped care, n (%) 15.21 15.79
Enhanced usual care, n (%) 16.43 14.89
Mean difference (95% CI)a 71.22 (72.89 to 0.46) 0.74 (71.05 to 2.53)
P 0.11 0.37
a. Adjusted for difference in baseline Revised Clinical Interview Schedule (CIS-R) score, age at baseline, gender and repeated observations by individuals.
3Fig. DS1 Impact of intervention on disability days (days out of or of reduced work in previous 30 days) at 2, 6 and 12 months. (a) Public
facilities, (b) private facilities.
Fig. DS2 Impact of the intervention on total disability scores (World Health Organization Disability Assessment Schedule II (WHODAS))
at 2, 6 and 12 months. (a) Public facilities, (b) private facilities.
